ISMPP US 2022 Global Annual Meeting

MAPPS-US-LB-010322 -60-


MAPPS-US-LB-010322 -76-

9–11 May

MAPPS-US-LB-010322 -78-

Washington, DC

Find us at booth 17

18th Annual Meeting of ISMPP: Washington, DC

We’re helping medical publication professionals become future-ready at the 18th Annual Meeting of ISMPP 2022. Oxford PharmaGenesis is an award-winning, independent, global HealthScience consultancy. We innovate for clients through our transformative services. We offer expertise in publications, strategic medical communications, informatics and data science, patient engagement, value demonstration and Open Pharma.

If you’re ready to explore new frontiers, Oxford PharmaGenesis is ready to help.

Meet us at booth 17

Exploring new frontiers

Patient Engagement

Let’s explore increasing patient involvement

We are committed to making a tangible difference to patient health. Our team of dedicated patient engagement specialists can help you understand the impact of evolving healthcare innovations. Let’s reach out to make meaningful patient connections at every stage of the drug development continuum.

Open Pharma

Let’s explore the future of pharma

Open Pharma is driving positive change in the communication of pharma-sponsored research at the frontiers of open science. Our goal is to accelerate the transparency, accountability, accessibility and discoverability of medical research. Together with pharma, publishers, patients and other stakeholders, we are building trust in healthcare communications.

Medical Affairs

Let’s explore the evolving landscape of Medical Affairs

Medical affairs is being transformed by the drive towards patient-centered, digitally-enabled engagement. We partner with our clients by offering full support on all medical affairs activities throughout the product life cycle, from evidence generation and strategy planning to clear communication of medical content tailored to physicians, patients, regulators, payers and

Informatics and Data Science

Let’s explore where data could take you

The universe of available biomedical data is constantly expanding. To use all these data to improve decision-making, we need an approach that sits at the intersection of healthcare information and technology: informatics. We help our clients navigate this dynamic and rapidly growing field. With our support, you’ll see through the data and discover powerful insights.

Value Demonstration

Let's explore ways to support patient access

Innovative and life-changing interventions need to be funded by healthcare systems worldwide and made available to the patients who need them the most. We help incorporate unmet need and health economic concepts into your strategies through effective communication and tactics to help support the reimbursement of new interventions and achieve broad patient access.

Strategic Medical Communications

Let’s explore new possibilities in medical communications

We apply a deep understanding of the science, audiences and channels to create persuasive medical communications across all forms of media. Our strategic planning process can take your medical communications to another level by connecting insights with medical objectives and evolving technological opportunities.


ORCID uptake in pharma-sponsored research

Paul Farrow, Caitlin Edgell, Sarah Sabir, Shawna Sadler (ORCID), James Munday, Christine Vanderlinden (GSK) and Santosh Mysore (GSK)

Awareness and use of scientific communication platforms: findings from a mid-sized pharmaceutical company employee survey

Elise Blankenship (Ipsen), Hollie Rawlings, David Gothard and Nisha Sheikh (Ipsen)

Real-life factors influencing journal selection

Nisha Sheikh (Ipsen), David Gothard, Anna Timbrell and Elise Blankenship (Ipsen)

Current trends in pharmaceutical industry-affiliated medRxiv and bioRxiv preprints

Susan Wieting (Takeda), Samuel Bestall, Kim Wager and Valérie Philippon (Takeda)

Can artificial intelligence be used to improve the efficiency of citation screening?

Christian Eichinger, Obaro Evuarherhe, Lisa Law, Marta Radwan, Carly Sellick, Tanina Cadwell (Vyasa), Mike Hugo (Vyasa) and Kim Wager

Measuring open access to pharmaceutical company-supported articles – an improved and semi-automated method

Elin Bevan, Tim Koder, Valérie Philippon (Takeda), Slavka Baronikova (Galapagos), Larisa Miller (Alexion), William Gattrell (Ipsen) and Tomas Rees


Parallel session

Best practice in dashboarding and interactive visualization for deeper insights from data

Tuesday 10 May 2022, 16:45–17:45 EDT – Richard White

Stopwatch session

Plain Language Summary Impact

Tuesday 10 May 2022, 16:45–17:45 EDT – Adeline Rosenberg

Oral presentation

Climate change commitments of leading pharmaceutical companies and their implications for the supply chain

Tuesday 10 May 2022, 14:10–14:40 EDT – Chris Winchester

Read our related news piece here

Roundtable session

Corporate and social responsibility expectations and implications

Tuesday 10 May 2022, 16:00–16:45 EDT – Chris Winchester

Get in touch

If you want to speak to one of our team about how we can support you, please fill in the contact form below.